[Intravesical therapy: Influence on superficial bladder cancer progression].

Autor:	García Rodríguez J; Servicio de Urología I, Hospital Central de Asturias, Oviedo, Asturias, España. jgrmed@hotmail.com, Fernández Gómez JM, Escaf Barmadah S, Alvarez Múgica M, Rodríguez Robles L, Martín Benito JL, San Martín Blanco A, Regadera Sejas J
Jazyk:	Spanish; Castilian
Zdroj:	Archivos espanoles de urologia [Arch Esp Urol] 2007 Jan-Feb; Vol. 60 (1), pp. 31-5.
Abstrakt:	Objectives: To review the influence of various intravesical treatments on superficial bladder cancer progression. Methods: We retrospectively reviewed 473 superficial bladder neoplasias. Based on diagnosis and transurethral resection of bladder tumor (TUR BT), and depending on pathology, we proposed different treatment and follow-up schemes, with BCG in 139 cases and intravesical chemotherapy, mainly Mytomicin C, in 80. Results: Overall, the use or not of bladder instillations did not show statistically significant differences in time to progression. The use of intravesical therapy and maintenance therapy was an independent risk factor for disease-free time to progression when compared with induction. Conclusions: The use of maintenance intravesical therapy with BCG resulted in a delayed progression of superficial bladder cancer, so that it seems the most effective treatment, mainly in moderate-high risk tumors.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu